Product Information
SEVELAMER HCL 800 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.6952 per EA under NDC 33342024257. Its NADAC has been published 118 times since Jul 3, 2024.
FDA first approved this application on May 26, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
800 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342024257
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SEVELAMER HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206883FDA Approved
5/26/2023
TE Code
AB
On Market Since
5/26/2023
Pharmacological Classes
Price Statistics
The NADAC for SEVELAMER HCL 800 MG TABLET has been published 118 times since Jul 3, 2024, and over the history we have for it it has declined 46.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6952 per EA |
|---|---|
| All-time high | $1.5808 (Sep 11, 2024) |
| All-time low | $0.6952 (Sep 23, 2026) |
| 52-week high | $1.3660 |
| 52-week low | $0.6952 |
| Median price | $1.2028 |
| Average price | $1.1561 |
| Largest weekly change | +18.2% (Jul 17, 2024) |
| Weeks tracked | 118 |
| Tracking since | Jul 3, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sevelamer Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phosphate Binder class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SEVELAMER HCL 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SEVELAMER HCL 800 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.6952 per EA (NDC 33342024257), effective Sep 30, 2026.
How has the price of SEVELAMER HCL 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for SEVELAMER HCL 800 MG TABLET has declined 46.0%. It has been tracked across 118 weekly CMS publications since Jul 3, 2024.
What are the highest and lowest recorded NADAC prices for SEVELAMER HCL 800 MG TABLET?
Since Jul 3, 2024, the NADAC for SEVELAMER HCL 800 MG TABLET has ranged from a low of $0.6952 (Sep 23, 2026) to a high of $1.5808 (Sep 11, 2024), with a median of $1.2028 per EA.
Are there cheaper alternatives to SEVELAMER HCL 800 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SEVELAMER HCL 800 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures SEVELAMER HCL 800 MG TABLET?
SEVELAMER HCL 800 MG TABLET (NDC 33342024257) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.